Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Alta Bates Summit Medical Center - Summit Campus
mi
from
Oakland, CA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Alta Bates Summit Medical Center - Summit Campus
mi
from
Oakland, CA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
CCOP - Bay Area Tumor Institute
mi
from
Oakland, CA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
CCOP - Bay Area Tumor Institute
mi
from
Oakland, CA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Desert Regional Medical Center Comprehensive Cancer Center
mi
from
Palm Springs, CA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Desert Regional Medical Center Comprehensive Cancer Center
mi
from
Palm Springs, CA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Valley Care Medical Center
mi
from
Pleasanton, CA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Valley Care Medical Center
mi
from
Pleasanton, CA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
University of California Davis Cancer Center
mi
from
Sacramento, CA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
University of California Davis Cancer Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
California Pacific Medical Center - California Campus
mi
from
San Francisco, CA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
California Pacific Medical Center - California Campus
mi
from
San Francisco, CA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Doctors Medical Center - San Pablo Campus
mi
from
San Pablo, CA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Doctors Medical Center - San Pablo Campus
mi
from
San Pablo, CA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
CCOP - Santa Rosa Memorial Hospital
mi
from
Sana Rosa, CA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
CCOP - Santa Rosa Memorial Hospital
mi
from
Sana Rosa, CA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Sutter Solano Medical Center
mi
from
Vallejo, CA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Sutter Solano Medical Center
mi
from
Vallejo, CA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Poudre Valley Hospital
mi
from
Fort Collins, CO
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Poudre Valley Hospital
mi
from
Fort Collins, CO
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Watson Clinic
mi
from
Lakeland, FL
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Watson Clinic
mi
from
Lakeland, FL
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Augusta Oncology Associates - Walton Way
mi
from
Augusta, GA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Augusta Oncology Associates - Walton Way
mi
from
Augusta, GA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
mi
from
Savannah, GA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
mi
from
Savannah, GA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Nancy N. and J. C. Lewis Cancer and Research Pavilion at St. Joseph's/Candler
mi
from
Savannah, GA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Nancy N. and J. C. Lewis Cancer and Research Pavilion at St. Joseph's/Candler
mi
from
Savannah, GA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
St. Luke's Mountain States Tumor Institute - Boise
mi
from
Boise, ID
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
St. Luke's Mountain States Tumor Institute - Boise
mi
from
Boise, ID
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Regional Cancer Center at Memorial Medical Center
mi
from
Springfield, IL
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Regional Cancer Center at Memorial Medical Center
mi
from
Springfield, IL
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
St. Francis Hospital and Health Centers - Beech Grove Campus
mi
from
Beech Grove, IN
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
St. Francis Hospital and Health Centers - Beech Grove Campus
mi
from
Beech Grove, IN
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Reid Hospital & Health Care Services, Incorporated
mi
from
Richmond, IN
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Reid Hospital & Health Care Services, Incorporated
mi
from
Richmond, IN
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Cancer Center of Kansas, PA - Chanute
mi
from
Chanute, KA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Cancer Center of Kansas, PA - Chanute
mi
from
Chanute, KA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Cancer Center of Kansas, PA - Dodge City
mi
from
Dodge City, KA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Cancer Center of Kansas, PA - Dodge City
mi
from
Dodge City, KA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Cancer Center of Kansas, PA - El Dorado
mi
from
El Dorado, KA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Cancer Center of Kansas, PA - El Dorado
mi
from
El Dorado, KA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
mi
from
Kansas City, KA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Cancer Center of Kansas, PA - Kingman
mi
from
Kingman, KA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Cancer Center of Kansas, PA - Kingman
mi
from
Kingman, KA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Southwest Medical Center
mi
from
Liberal, KA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Southwest Medical Center
mi
from
Liberal, KA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Cancer Center of Kansas, PA - Newton
mi
from
Newton, KA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Cancer Center of Kansas, PA - Newton
mi
from
Newton, KA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Cancer Center of Kansas, PA - Parsons
mi
from
Parsons, KA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Cancer Center of Kansas, PA - Parsons
mi
from
Parsons, KA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Cancer Center of Kansas, PA - Pratt
mi
from
Pratt, KA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Cancer Center of Kansas, PA - Pratt
mi
from
Pratt, KA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Cancer Center of Kansas, PA - Salina
mi
from
Salina, KA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Cancer Center of Kansas, PA - Salina
mi
from
Salina, KA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Tammy Walker Cancer Center at Salina Regional Health Center
mi
from
Salina, KA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Tammy Walker Cancer Center at Salina Regional Health Center
mi
from
Salina, KA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Cancer Center of Kansas, PA - Wellington
mi
from
Wellington, KA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Cancer Center of Kansas, PA - Wellington
mi
from
Wellington, KA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Associates in Womens Health, PA - North Review
mi
from
Wichita, KA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Associates in Womens Health, PA - North Review
mi
from
Wichita, KA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Cancer Center of Kansas, PA - Medical Arts Tower
mi
from
Wichita, KA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Cancer Center of Kansas, PA - Medical Arts Tower
mi
from
Wichita, KA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Cancer Center of Kansas, PA - Wichita
mi
from
Wichita, KA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Cancer Center of Kansas, PA - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
CCOP - Wichita
mi
from
Wichita, KA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Via Christi Cancer Center at Via Christi Regional Medical Center
mi
from
Wichita, KA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Via Christi Cancer Center at Via Christi Regional Medical Center
mi
from
Wichita, KA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Wesley Medical Center
mi
from
Wichita, KA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Wesley Medical Center
mi
from
Wichita, KA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Cancer Center of Kansas, PA - Winfield
mi
from
Winfield, KA
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Cancer Center of Kansas, PA - Winfield
mi
from
Winfield, KA
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Markey Cancer Center at University of Kentucky Chandler Medical Center
mi
from
Lexington, KY
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Markey Cancer Center at University of Kentucky Chandler Medical Center
mi
from
Lexington, KY
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Battle Creek Health System Cancer Care Center
mi
from
Battle Creek, MI
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Battle Creek Health System Cancer Care Center
mi
from
Battle Creek, MI
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Mecosta County Medical Center
mi
from
Big Rapids, MI
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Mecosta County Medical Center
mi
from
Big Rapids, MI
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Josephine Ford Cancer Center at Henry Ford Hospital
mi
from
Detroit, MI
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Josephine Ford Cancer Center at Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
CCOP - Grand Rapids
mi
from
Grand Rapids, MI
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
CCOP - Grand Rapids
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Lacks Cancer Center at Saint Mary's Health Care
mi
from
Grand Rapids, MI
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Lacks Cancer Center at Saint Mary's Health Care
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Spectrum Health Hospital - Butterworth Campus
mi
from
Grand Rapids, MI
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Spectrum Health Hospital - Butterworth Campus
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Metro Health Hospital
mi
from
Grand Rapids, MI
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Metro Health Hospital
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Holland Community Hospital
mi
from
Holland, MI
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Holland Community Hospital
mi
from
Holland, MI
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Hackley Hospital
mi
from
Muskegon, MI
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Hackley Hospital
mi
from
Muskegon, MI
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
Munson Medical Center
mi
from
Traverse City, MI
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
Munson Medical Center
mi
from
Traverse City, MI
Click here to add this to my saved trials
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated:  11/16/2015
CCOP - Kansas City
mi
from
Kansas City, MO
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial With Molecular Correlates
Status: Enrolling
Updated: 11/16/2015
CCOP - Kansas City
mi
from
Kansas City, MO
Click here to add this to my saved trials